证券代码：603297 证券简称：永新光学 公告编号：2023-050 宁波永新光学股份有限公司 第八届董事会第三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 宁波永新光学股份有限公司（以下简称"公司"）于 2023 年 8 月 20 日以电 子邮件及专人送达方式发出了关于召开公司第八届董事会第三次会议的通知，本 次会议于 2023 年 8 月 25 日以现场结合通讯方式召开。本次会议应出席董事 9 名，实际出席董事 9 名，公司监事及高级管理人员列席会议，会议由联席董事长 毛磊先生主持。本次会议的召开符合《中华人民共和国公司法》和《公司章程》 的有关规定，所作决议合法有效。 二、董事会会议审议情况 经过充分讨论，会议审议并通过了如下决议： 1、审议并通过《2023 年半年度报告全文及摘要》 具体内容详见公司刊载于上海证券交易所网站（www.sse.com.cn）和公司指 定信息披露媒体的《2023 年半年度报告》全文及《2023 年半年度报告摘要》。 表决结果：同意 9 票；反对 0 ...

证券代码：603297 证券简称：永新光学 公告编号：2023-051 宁波永新光学股份有限公司 第八届监事会第三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 宁波永新光学股份有限公司（以下简称"公司"）于 2023 年 8 月 20 日以电 子邮件及专人送达方式发出了关于召开公司第八届监事会第三次会议的通知，本 次会议于 2023 年 8 月 25 日在公司会议室召开。会议应出席监事 3 名，实际出席 监事 3 名。本次会议由监事会主席周辉先生主持。本次会议的召开符合《中华人 民共和国公司法》和《公司章程》的有关规定，所作决议合法有效。 二、监事会会议审议情况 经过充分讨论，会议审议并通过了如下决议： 1、审议并通过《2023 年半年度报告全文及摘要》 具体内容详见公司刊载于上海证券交易所网站（www.sse.com.cn）和公司指 定信息披露媒体的《2023 年半年度报告》全文及《2023 年半年度报告摘要》。 表决结果：同意 3 票；反对 0 票；弃权 0 票。 2、审议并通过《 ...

宁波永新光学股份有限公司 独立董事关于第八届董事会第三次会议 相关事项的独立意见 根据《公司法》《上市公司独立董事制度》《公司章程》及《公司独立董事 工作制度》等有关规定，我们作为宁波永新光学股份有限公司（以下简称"公司"） 的独立董事，认真审阅了公司第八届董事会第三次会议审议事项，发表独立意见 如下： 一、关于 2023 年半年度募集资金存放与使用情况的专项报告的独立意见 2023 年 1-6 月公司对于募集资金的存放使用均符合《证券法》《上海证券 交易所股票上市规则》及《上市公司监管指引第 2 号——上市公司募集资金管理 和使用的监管要求》等有关法律、法规和规范性文件以及公司章程、公司募集资 金管理办法的规定，不存在变更募集资金投资项目的情况，亦不存在未及时、真 实、准确、完整披露募集资金使用的情况，募集资金的存放与使用情况合法合规。 综上，作为公司独立董事，我们认为本次董事会会议的召开和表决程序符合 法律、法规、规范性文件和《公司章程》的规定，会议履行了法定程序，会议形 成的决议合法、有效。 ...

证券代码：603297 证券简称：永新光学 公告编号：2023-023 宁波永新光学股份有限公司 关于召开2022年年度网上业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 会议召开时间：2023 年 5 月 18 日 10:00-11:00 会议召开方式：文字网络互动 会议召开地点：证券日报网路演平台（http://www.zqrb.cn/huiyi/lyhd/ind ex.html） 投资者可于 2023 年 5 月 17 日 17:00 前通过公告中的联系电话、电子邮 箱联系公司，提出所关注的问题，公司将在说明会上就投资者普遍关注的问题 进行回答。 一、说明会类型 宁波永新光学股份有限公司（以下简称"公司"）已于 2023 年 4 月 25 日在 上海证券交易所网站（www.sse.com.cn）披露了《2022 年年度报告》。为方便 广大投资者更加全面、深入地了解公司情况，公司定于 2023 年 5 月 18 日（星期 四）10:00-11:00 在证券日报网路演平台以网络互动方式 ...

Financial Performance - The company's operating revenue for 2022 was RMB 829,073,673.15, representing a 4.27% increase compared to RMB 795,093,310.90 in 2021[24]. - The net profit attributable to shareholders for 2022 was RMB 278,984,393.25, which is a 6.70% increase from RMB 261,463,348.36 in 2021[24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 216,469,454.02, marking a significant increase of 34.64% from RMB 160,771,333.47 in 2021[24]. - The net cash flow from operating activities for 2022 was RMB 216,081,596.60, up 24.74% from RMB 173,231,266.34 in 2021[24]. - Basic earnings per share increased by 6.28% to CNY 2.54 in 2022 from CNY 2.39 in 2021[26]. - The company's net profit attributable to shareholders for Q4 2022 was CNY 80,089,312.93, showing a significant increase compared to previous quarters[28]. - The total operating income for Q4 2022 was CNY 221,294,822.84, reflecting a strong performance in the last quarter[28]. - The company achieved a total revenue of 829 million yuan, representing a year-on-year growth of 4.27%[36]. - The net profit attributable to shareholders, excluding non-recurring gains and losses, reached 216 million yuan, up 34.64% compared to the previous year[36]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion RMB for the fiscal year 2022, representing a year-over-year growth of 15%[123]. Assets and Investments - The total assets at the end of 2022 were RMB 1,913,023,445.64, an increase of 11.58% from RMB 1,714,469,507.97 at the end of 2021[25]. - The net assets attributable to shareholders at the end of 2022 were RMB 1,666,859,720.86, reflecting a 12.92% increase from RMB 1,476,123,801.45 at the end of 2021[25]. - The company reported a net cash outflow from investment activities of ¥505,750,923.36, a significant decrease from a net inflow of ¥33,359,826.08 in the previous year[78]. - The company received government subsidies amounting to ¥34,698,321.85, representing 11.26% of total profit[92]. - The investment income from financial products was ¥19,386,368.27, accounting for 6.29% of total profit[92]. Research and Development - R&D investment reached CNY 79.39 million, a year-on-year increase of 25.87%, accounting for 9.58% of main business revenue[34]. - The company completed the development and trial of the NSR950 super-resolution microscope, which is significant for developing proprietary technology[35]. - The company is leading a national key R&D project focused on ophthalmic surgical navigation microscopes, which is expected to advance specialized instruments in various medical fields[35]. - The company has successfully developed and sold dozens of confocal microscopes, with over 100 trial customers including research institutions and hospitals[38]. - The company completed the R&D of the NCF950 laser confocal microscope system and achieved stable mass production of 10x—100x full set of achromatic lenses and endoscope lenses, obtaining 31 authorized patents during the reporting period, including 11 invention patents[43]. - The company invested over CNY 60 million in information technology and automation throughout the year to enhance smart manufacturing capabilities[35]. Market and Industry Trends - The global optical microscope market is expected to reach $6.1 billion by 2026, driven by increased investment in life sciences research and the demand for high-precision, automated, and intelligent devices[55]. - The global barcode scanner market was valued at $6.94 billion in 2021 and is projected to reach $10.77 billion by 2027, with a CAGR of 7.6% from 2021 to 2027[59]. - The domestic machine vision industry in China reached a scale of 16.8 billion yuan in 2022, representing a year-on-year growth of approximately 22%, and is expected to reach 27.5 billion yuan by 2025[60]. - The Chinese medical device market is projected to grow to 1.2295 trillion yuan by 2024, with a CAGR of 14.5%[63]. - The surgical microscope market is dominated by foreign brands like Zeiss, Leica, and Olympus, which hold approximately 80% of the market share[64]. Corporate Governance and Management - The company held 1 annual general meeting and 3 extraordinary general meetings during the reporting period, ensuring equal rights for all shareholders, especially minority shareholders[110]. - The board of directors consists of 9 members, including 3 independent directors, and held 7 meetings during the reporting period, adhering to legal and regulatory requirements[111]. - The supervisory board, comprising 3 members, conducted 6 meetings, ensuring compliance with legal and regulatory standards[112]. - The company disclosed 4 periodic reports and 82 temporary reports, totaling 137 disclosures, achieving a B-level evaluation from the Shanghai Stock Exchange for information disclosure[112]. - The company has established effective internal controls, with no significant deficiencies reported as of December 31, 2022[112]. - The company has implemented measures to ensure the independence of its operations and governance structure[113]. Employee Engagement and Incentives - The company has established a "Youth Talent Cultivation Plan" to promote a younger management team, with 51 middle and senior management personnel born in the 1980s and 1990s, accounting for nearly 60% of the total[48]. - The company implemented an employee stock ownership plan and a restricted stock incentive plan, benefiting 91 incentive objects and enhancing the stability and motivation of the core talent team[49]. - The company conducted training for 1,590 employees, totaling 5,340 hours, focusing on enhancing the skills of R&D personnel and frontline employees[146]. - A total of 57 middle management and key employees were granted 1.345 million restricted stock options as part of the incentive plan[144]. - The company implemented a performance evaluation mechanism for senior management, combining base salary and performance pay, with assessments based on operational and management goals[155]. Sustainability and Environmental Commitment - The company invested 5.6 million yuan in environmental protection during the reporting period, reflecting its commitment to sustainable practices[160]. - The company was recognized as a national "Green Factory" and a "Zhejiang Province Water-Saving Benchmark Enterprise," emphasizing its focus on green development strategies[162]. - The company has adopted clean energy generation measures to reduce carbon emissions, although specific reduction figures were not disclosed[163]. - The company plans to further enhance its green manufacturing capabilities and explore new strategies for sustainable development[162]. Future Outlook and Strategic Goals - The company aims to achieve a fivefold growth over five years, focusing on precision manufacturing in the optical perception field, with a strategic goal to become a globally recognized optical enterprise by 2035[101]. - The company plans to expand its core businesses in optical microscopes and barcode machine vision while also venturing into emerging sectors such as LiDAR and medical optics[103]. - The company provided a positive outlook for 2023, projecting a revenue growth of 10% to 1.32 billion RMB, driven by new product launches and market expansion strategies[123]. - The company plans to expand its market presence in Southeast Asia, targeting a 30% increase in sales from this region by 2024[123]. - A strategic acquisition of a local competitor is expected to be finalized in Q2 2023, which is anticipated to enhance market share by 5%[123].

Financial Performance - Revenue for Q1 2023 was CNY 188,173,306.31, a decrease of 9.96% compared to the same period last year[4] - Net profit attributable to shareholders was CNY 47,384,796.49, down 12.26% year-on-year[4] - The total profit for the quarter was CNY 52,965,474.36, compared to CNY 60,888,929.23 in the same period last year[14] - Basic and diluted earnings per share for Q1 2023 were CNY 0.43, down from CNY 0.49 in Q1 2022, a decrease of 12.24%[47] - The company reported a total comprehensive income of CNY 47,144,952.72 for Q1 2023, down from CNY 53,917,867.19 in Q1 2022, a decline of 12.56%[47] Cash Flow and Liquidity - Net cash flow from operating activities increased significantly to CNY 45,184,491.90, a rise of 1,053.34% compared to the previous year[4] - Cash inflow from operating activities totaled CNY 232,405,703.68 in Q1 2023, compared to CNY 214,368,492.82 in Q1 2022, an increase of 8.43%[47] - Cash and cash equivalents at the end of the period were CNY 424,519,511.87, down from CNY 593,977,320.74 at the end of the previous year[15] - The net increase in cash and cash equivalents for the quarter was CNY 151,295,912.21, compared to a decrease of CNY 15,767,125.85 in the previous year[15] - Cash and cash equivalents increased to CNY 424,519,511.87 as of March 31, 2023, compared to CNY 273,223,599.66 at the end of 2022, representing a growth of 55.53%[40] Expenses and Investments - R&D expenses for the quarter were CNY 19,237,182.11, an increase from CNY 17,356,193.34 in the same period last year[14] - Investment income for the quarter was CNY 9,334,676.06, compared to CNY 4,790,460.42 in the previous year[14] Assets and Liabilities - Total assets increased by 3.53% to CNY 1,980,630,841.10 compared to CNY 1,913,023,445.64 at the end of the previous year[35] - Total current liabilities increased to CNY 230,803,092.46, up from CNY 210,567,478.05, marking a rise of approximately 9.9%[23] - Total liabilities increased to CNY 264,496,369.85 as of March 31, 2023, compared to CNY 245,133,153.04 at the end of 2022, marking an increase of 7.88%[41] - Non-current liabilities decreased slightly from CNY 34,565,674.99 to CNY 33,693,277.39, a reduction of approximately 2.5%[23] Equity and Returns - The owner's equity attributable to shareholders of the listed company rose by 2.90% to CNY 1,715,263,259.58 from CNY 1,666,859,720.86[35] - Total equity attributable to shareholders reached CNY 1,715,263,259.58 as of March 31, 2023, compared to CNY 1,666,859,720.86 at the end of 2022, reflecting an increase of 2.91%[41] - The weighted average return on net assets was 3.16%, up from -0.43% in the previous year[34] Other Financial Metrics - Diluted earnings per share improved to CNY 0.43, a significant recovery from a loss of CNY -12.24 in the previous period[34] - Long-term prepaid expenses decreased from CNY 1,197,812.89 to CNY 1,016,551.90, reflecting a reduction of approximately 15.1%[23] - Deferred income tax assets slightly decreased from CNY 7,349,102.66 to CNY 7,287,469.16, a decline of about 0.84%[23] - Contract liabilities rose significantly from CNY 16,045,689.84 to CNY 25,623,081.69, an increase of about 59.7%[23] - Total operating costs for Q1 2023 were CNY 155,024,437.87, down from CNY 162,643,471.02 in Q1 2022, reflecting a reduction of 4.00%[41] - Inventory as of March 31, 2023, was CNY 204,199,785.28, up from CNY 187,848,610.75 at the end of 2022, indicating an increase of 8.66%[40]

Financial Performance - The company's operating revenue for Q3 2022 was ¥195,929,554.71, a decrease of 7.86% compared to the same period last year[6] - Net profit attributable to shareholders for Q3 2022 was ¥62,203,681.54, an increase of 15.71% year-on-year[6] - The net profit after deducting non-recurring gains and losses was ¥51,950,498.78, reflecting a growth of 7.26% compared to the previous year[9] - The basic earnings per share for Q3 2022 was ¥0.56, up 14.29% year-on-year[9] - Net profit for Q3 2022 was ¥198,630,042.98, down from ¥217,582,811.00 in Q3 2021, reflecting a decrease of about 8.7%[32] - Basic earnings per share for Q3 2022 were ¥1.80, compared to ¥1.97 in Q3 2021, showing a decline of approximately 8.6%[34] - The total comprehensive income for Q3 2022 was ¥198,267,844.13, down from ¥217,469,275.64 in Q3 2021, reflecting a decrease of about 8.8%[34] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,828,459,100.16, representing a 6.66% increase from the end of the previous year[9] - The company's cash and cash equivalents decreased to CNY 345,559,111.66 from CNY 609,764,446.59, reflecting a decline of about 43.38% year-over-year[19] - The accounts receivable increased to CNY 181,430,048.27 from CNY 159,281,438.35, showing an increase of approximately 13.91%[19] - Inventory levels rose to CNY 186,644,349.61 from CNY 175,328,763.48, indicating a growth of about 6.52%[19] - The company's total current liabilities increased to CNY 228,608,380.24 from CNY 220,633,210.88, marking an increase of approximately 3.93%[22] - Total liabilities amounted to ¥240,916,137.56, slightly up from ¥236,691,007.09 in the previous period[24] - Total equity attributable to shareholders reached ¥1,586,302,294.41, an increase from ¥1,476,131,671.77 year-over-year[24] Cash Flow - Cash flow from operating activities for the year-to-date was ¥118,085,181.69, an increase of 45.87% year-on-year[9] - The net cash flow from operating activities for the first three quarters of 2022 was CNY 118,085,181.69, an increase of 45.5% compared to CNY 80,953,737.11 in the same period of 2021[39] - Total cash inflow from operating activities reached CNY 699,282,146.43, up from CNY 589,748,340.80, reflecting a growth of 18.6% year-over-year[39] - Cash outflow from operating activities totaled CNY 581,196,964.74, compared to CNY 508,794,603.69 in the previous year, indicating an increase of 14.2%[39] - The company reported cash inflow from investment activities of CNY 523,745,255.33, a decrease of 40.9% from CNY 887,278,536.05 in the same period last year[39] - The net cash flow from investment activities was negative at CNY -339,941,915.91, contrasting with a positive CNY 14,811,879.43 in the previous year[39] - Cash inflow from financing activities was CNY 140,000,000.00, significantly higher than CNY 25,000,000.00 in the same period of 2021[39] - The net cash flow from financing activities was CNY -84,252,533.47, compared to CNY -59,882,028.66 in the previous year, indicating a worsening cash position[39] - The ending cash and cash equivalents balance was CNY 345,358,262.39, down from CNY 508,499,561.25 at the end of the previous year[39] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 12,947[13] - The largest shareholder, 永新光电实业有限公司, held 29.16% of the shares, totaling 32,217,250 shares[13] Research and Development - Research and development expenses increased to ¥59,543,874.00 in Q3 2022, up from ¥46,099,985.14 in Q3 2021, indicating a rise of approximately 29.2%[28]

Financial Performance - The company's operating revenue for the first half of the year reached ¥411,849,295.60, an increase of 11.81% compared to ¥368,351,439.96 in the same period last year[26]. - Net profit attributable to shareholders decreased by 16.56% to ¥136,691,398.78 from ¥163,822,430.07 year-on-year[26]. - The net profit after deducting non-recurring gains and losses increased by 45.85% to ¥108,607,915.61, driven by revenue growth and increased exchange gains[26]. - The net cash flow from operating activities surged by 155.87% to ¥89,089,259.48, attributed to increased sales and reduced tax payments[26]. - Basic earnings per share decreased by 16.22% to ¥1.24, while diluted earnings per share fell by 15.75% to ¥1.23[26]. - The weighted average return on net assets decreased by 3.28 percentage points to 8.94%[26]. - The company reported a total asset value of ¥1,896,817,330.42, reflecting a 10.64% increase from the previous year[26]. - The company reported a total revenue of 1.5 billion RMB for the first half of 2022, representing a year-over-year increase of 15%[134]. - The company’s operating revenue for the reporting period reached ¥411,849,295.60, representing an increase of 11.81% compared to ¥368,351,439.96 in the same period last year[67]. - The total profit for the first half of 2022 was approximately CNY 155.93 million, a decrease of 17.8% from CNY 189.70 million in the first half of 2021[191]. Market Outlook - The optical microscope market is projected to reach $6.1 billion by 2026, indicating stable demand and growth opportunities[33]. - The barcode scanner market is expected to grow at a CAGR of 7%-8%, potentially reaching $13.7 billion by 2031[36]. - The domestic machine vision industry is anticipated to grow from ¥150 billion in 2021 to ¥275 billion by 2025, highlighting significant growth potential[37]. - The Chinese projector market shipped 4.7 million units in 2021, representing a year-on-year growth of 12.6%, with a projected five-year compound annual growth rate (CAGR) exceeding 15.0% by 2025[40]. - The global automotive camera market is expected to reach $27.3 billion by 2025, driven by advancements in technology and increased consumer safety awareness[41]. - The global lidar market is projected to reach $13.54 billion by 2025, with China anticipated to become the largest market for autonomous driving[41]. Research and Development - The company has developed core optical components for high-end products, including super-resolution microscopy systems, and has completed the manufacturing of FSED super-resolution systems[49]. - The company holds 120 patents, including 33 invention patents, enhancing its core competitiveness in the optical precision manufacturing sector[49]. - R&D investment reached 40.026 million yuan, up 43.82% year-on-year, accounting for 9.72% of main business revenue[61]. - Research and development expenses rose significantly by 43.82% to ¥40,025,973.00, compared to ¥27,830,378.79 in the previous year, reflecting increased investment in R&D[69]. - The company has increased its R&D investment and actively sought high-quality customer resources to navigate challenges posed by the pandemic and market competition[51]. Corporate Governance - The board of directors confirmed the authenticity, accuracy, and completeness of the semi-annual report[3]. - The company has appointed a new non-independent director, Jiang Jianjun, following the resignation of Jin Xiaolong[90]. - The company has appointed Xi Jingpeng as the new board secretary after the resignation of Li Zhourong[93]. - The company has developed a corporate culture manual to integrate its core values into daily operations and employee behavior, supporting sustainable development[67]. - The company will ensure that the remuneration system for the board of directors and the compensation and assessment committee is linked to the execution of the compensation measures[128]. Risk Management - The company has described potential risks in the report, urging investors to pay attention[11]. - The company faces risks related to technological innovation, as it must continuously enhance R&D and launch new products to avoid negative impacts on future development[80]. - The company is exposed to foreign exchange risks due to its overseas customer settlements primarily in USD, which may lead to exchange losses if not managed effectively[80]. - The company is affected by macroeconomic downturn risks, with global economic slowdown impacting consumer capacity and investment willingness in the supply chain[81]. - The company has a risk of market expansion related to new production capacity, which may face challenges if market demand declines due to adverse changes in the macroeconomic environment[82]. Shareholder Information - The company did not distribute profits or increase capital reserves in the first half of 2022[5]. - The company does not plan to distribute profits or increase share capital from capital reserves for the first half of 2022[94]. - The company reported a commitment period for share restrictions from September 10, 2018, to September 9, 2023, during which shareholders cannot transfer or manage their shares[112]. - Shareholders are restricted from transferring more than 25% of their shares during their tenure and for six months after leaving the company[115]. - The company’s shareholding structure includes significant commitments from major shareholders to maintain their stakes[112]. Operational Efficiency - The company has established a multi-level training system to strengthen talent development, including specific programs for middle management and new graduates[66]. - The company plans to enhance its internal control management and improve operational efficiency to ensure the effectiveness of its internal control system[124]. - The company aims to establish a comprehensive performance evaluation system and implement competitive compensation policies to improve employee efficiency and reduce operational costs[124]. - The company has committed to managing and using raised funds in compliance with relevant laws and regulations, ensuring dedicated use of funds[124]. Capital Management - The company has successfully implemented an employee stock ownership plan, allowing 91 incentive recipients to realize equity rewards, enhancing team stability and motivation[66]. - The company will adopt legal methods for share reduction, including block trades and public announcements three trading days prior to any reduction[122]. - The company will implement measures to stabilize stock prices, including stock buybacks and increasing holdings by major shareholders if necessary[122]. - The company has established a management system for raised funds to ensure proper oversight and usage[124].

Financial Performance - The company's operating revenue for Q1 2022 was ¥208,986,177.91, representing a year-on-year increase of 21.23%[6] - The net profit attributable to shareholders of the listed company was ¥54,007,062.24, showing a significant decrease of 55.00% compared to the same period last year[6] - Basic earnings per share were ¥0.49, down 55.45% from the previous year[6] - The diluted earnings per share also stood at ¥0.49, a decrease of 55.05% year-on-year[6] - Net profit for Q1 2022 was CNY 53,873,900.82, a decrease of 55.1% compared to CNY 119,816,694.10 in Q1 2021[29] - The company reported a total comprehensive income of CNY 53,917,867.19 for Q1 2022, compared to CNY 119,833,047.72 in Q1 2021[31] Cash Flow - The net cash flow from operating activities was ¥3,917,723.42, reflecting a decline of 83.53% year-on-year[6] - Total cash inflow from operating activities was approximately CNY 214.37 million, an increase from CNY 178.88 million in the previous year, representing a growth of 19.87%[35] - Net cash flow from operating activities decreased to CNY 3.92 million from CNY 23.79 million, a decline of 83.53% year-over-year[35] - Total cash inflow from investment activities was CNY 254.31 million, down from CNY 326.49 million, a decrease of 22.08%[35] - Net cash flow from investment activities was negative CNY 16.75 million, compared to a positive CNY 46.27 million in the previous year[35] - Cash outflow from financing activities totaled CNY 1.12 million, compared to CNY 0.79 million, an increase of 41.00%[35] - The ending balance of cash and cash equivalents was CNY 593.98 million, down from CNY 545.22 million, a decrease of 8.93% year-over-year[37] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,725,003,811.03, a slight increase of 0.62% from the end of the previous year[9] - The equity attributable to shareholders of the listed company was ¥1,532,199,129.24, up 3.80% from the end of the previous year[9] - Total liabilities as of the reporting date were CNY 191,432,137.68, down from CNY 236,691,007.09 in the previous period[25] - Total current liabilities decreased to RMB 178,157,169.19 from RMB 220,633,210.88, a reduction of about 19.2%[23] Operational Costs and Expenses - Total operating costs for Q1 2022 were CNY 162,643,471.02, up 25.3% from CNY 129,794,610.93 in Q1 2021[29] - R&D expenses in Q1 2022 amounted to CNY 17,356,193.34, an increase of 45.0% from CNY 11,984,650.46 in Q1 2021[29] - Cash paid for purchasing goods and services increased to CNY 129.40 million from CNY 85.74 million, a rise of 50.83%[35] - Cash paid to employees rose to CNY 48.30 million from CNY 34.49 million, an increase of 40.06%[35] - Cash paid for taxes decreased to CNY 12.21 million from CNY 18.12 million, a decline of 32.54%[35] Non-Recurring Items - Non-recurring gains and losses amounted to ¥13,277,528.09, primarily due to government subsidies and other income[10] - The decrease in net profit was mainly attributed to a reduction in land compensation received in the same period last year[10]

Financial Performance - The company's operating revenue for 2021 was RMB 795,093,310.90, representing a year-on-year increase of 37.94% compared to RMB 576,409,916.27 in 2020[20]. - The net profit attributable to shareholders of the listed company reached RMB 261,471,218.68, marking a significant increase of 61.72% from RMB 161,683,777.61 in the previous year[20]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 160,779,203.79, up 69.26% from RMB 94,991,936.14 in 2020[20]. - The net cash flow from operating activities was RMB 173,231,266.34, showing a decrease of 8.22% compared to RMB 188,752,935.26 in the previous year[20]. - Basic earnings per share increased by 61.49% to CNY 2.39 in 2021 compared to CNY 1.48 in 2020[22]. - The company's revenue for the fourth quarter reached CNY 214,104,584.99, with a total annual revenue growth driven by increased sales of optical components and microscopes[24]. - The net profit attributable to shareholders for the first quarter was CNY 120,004,372.00, while the annual net profit increased significantly due to revenue growth and reduced management and financial expenses[24]. - The company achieved operating revenue of CNY 795.09 million, a year-on-year increase of 37.94%[58]. - Net profit attributable to shareholders was CNY 261.47 million, reflecting a 61.72% increase year-on-year[58]. Assets and Liabilities - The total assets at the end of 2021 amounted to RMB 1,714,328,384.39, an increase of 17.30% from RMB 1,461,519,990.41 at the end of 2020[21]. - The net assets attributable to shareholders of the listed company were RMB 1,476,131,671.77, reflecting a growth of 17.31% from RMB 1,258,376,571.97 in 2020[21]. - The company's cash and cash equivalents increased by 28.68% to ¥609,764,446.59, making up 35.57% of total assets[76]. - The total assets at the end of the period were significantly impacted by an increase in financial investments, with trading financial assets rising by 77.78% to ¥240,000,000[76]. - The company's total liabilities increased from 203,143,400 to 236,691,000 during the reporting period[199]. Dividends and Shareholder Returns - The company plans to distribute a cash dividend of RMB 9.00 per 10 shares, totaling RMB 99,429,750.00 based on the total share capital of 110,477,500 shares[4]. - The company implemented a cash dividend policy, distributing a total of RMB 58,562,350.00 (including tax) to shareholders based on a total share capital of 110,495,000 shares, at a rate of RMB 5.30 per 10 shares[141]. - The cash dividend policy stipulates that at least 20% of the distributable profits for the year should be distributed in cash if conditions are met[142]. Research and Development - R&D investment reached 63.07 million yuan, a year-on-year increase of 33.39%, accounting for 8.10% of main business revenue[35]. - The company has established partnerships with top universities, enhancing its research capabilities and technology transfer[56]. - Research and development expenses increased by 33.39% to CNY 63.07 million, indicating a focus on innovation[60]. - The company is focused on the R&D of mid-to-high-end optical components in fields such as barcode scanning, lithography lenses, and LiDAR, accelerating the development of OEM products towards complexity and modularization[93]. - The company is investing 200 million RMB in research and development to innovate new technologies in optical solutions[162]. Market Expansion and Strategy - The company is focusing on expanding high-end emerging businesses in response to trends in automation and artificial intelligence[30]. - The company is expanding into emerging business areas such as automotive optics, machine vision, and laser radar, in addition to its core businesses[53]. - The company is expanding its market presence in Southeast Asia, targeting a 25% market share by 2025[115]. - The company plans to enhance its online sales channels, aiming for a 50% increase in e-commerce revenue[115]. - The company has set a future outlook with a revenue target of 1.5 billion RMB for 2022, indicating a growth forecast of 25%[165]. Corporate Governance and Compliance - The company has provided a standard unqualified audit report from Tianjian Accounting Firm[3]. - The company has established effective internal controls, with no significant deficiencies reported as of December 31, 2021[103]. - The company has established effective risk control mechanisms for its subsidiaries, focusing on operational management and financial oversight[147]. - The company has committed to ensuring that the prospectus for the initial public offering (IPO) does not contain false records, misleading statements, or significant omissions, and will bear individual and joint legal responsibility for its authenticity, accuracy, and completeness[168]. - The company has established measures to minimize investor losses in case of non-fulfillment of commitments[169]. Employee and Management - The company employed 319 R&D personnel, representing 26.34% of the total workforce[70]. - The company has established effective incentive mechanisms, with 388,500 restricted stocks released to 53 incentive objects, enhancing team stability[39]. - The company implemented a differentiated compensation policy, including wages, allowances, bonuses, and benefits, to align employee interests with shareholder and company interests[138]. - The company’s training initiatives aim to foster employee dedication, enhance professional skills, and promote teamwork[139]. - The company has a total of 272.92 million CNY in net assets, indicating a solid financial position[108]. Product Development and Innovation - The high-end optical microscope brand NEXCOPE achieved sales exceeding CNY 60 million, with a year-on-year growth of over 50%[30]. - New product launches included two innovative optical devices, expected to contribute an additional 200 million RMB in revenue[115]. - New product development includes the launch of a cutting-edge optical lens, expected to contribute an additional 200 million RMB in revenue in the next fiscal year[166]. - The company has developed liquid focus lenses that significantly enhance production efficiency, positioning itself as one of the first to achieve mass production of such technology[48]. Risk Management - The company has committed to avoiding and minimizing related party transactions, ensuring fair pricing in any unavoidable transactions[159]. - The company has established a commitment to not use related party transactions to illegally transfer funds or profits from the company[159]. - The company will ensure that the compensation system for the board of directors is linked to the execution of the measures to compensate for the dilution of immediate returns[167]. - The company will take necessary actions to protect investor interests in case of non-fulfillment of commitments[169].